Correction to: mTOR inhibitor INK128 promotes wound healing by regulating MDSCs

Correction to: mTOR inhibitor INK128 promotes wound healing by regulating MDSCs

Bibliographic Details
Main Authors:	Yi Li, Yujun Xu, Xinghan Liu, Xin Yan, Yue Lin, Qian Tan, Yayi Hou
Format:	Article
Language:	English
Published:	BMC 2021-09-01
Series:	Stem Cell Research & Therapy
Online Access:	https://doi.org/10.1186/s13287-021-02569-2

Similar Items

mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
by: Yi Li, et al.
Published: (2021-03-01)

Correction to: Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yaxian Xue, et al.
Published: (2022-01-01)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yujun Xu, et al.
Published: (2019-12-01)

MDSCs participate in the pathogenesis of diffuse pulmonary hemorrhage in murine lupus through mTOR-FoxO1 signaling
by: Liping Tan, et al.
Published: (2022-12-01)

mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD
by: Xiaoqing Li, et al.
Published: (2021-12-01)

High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line
by: Sijiao Wang, et al.
Published: (2024-03-01)

Accelerated wound healing by mTOR activation in genetically defined mouse models.
by: Cristiane H Squarize, et al.
Published: (2010-05-01)

A review of photobiomodulation on PI3K/AKT/mTOR in wound healing
by: Patricia Kasowanjete, et al.
Published: (2024-02-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

Targeting ganglioneuromas with mTOR inhibitors
by: Ting Tao, et al.
Published: (2021-01-01)

MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing.
by: Yi Jin, et al.
Published: (2013-01-01)

Burn Ointment Promotes Cutaneous Wound Healing by Modulating the PI3K/AKT/mTOR Signaling Pathway
by: Dali Gan, et al.
Published: (2021-03-01)

Cancer and mTOR inhibitors in kidney transplantation recipients
by: Chih-Chin Kao, et al.
Published: (2018-11-01)

Ropivacaine inhibits wound healing by suppressing the proliferation and migration of keratinocytes via the PI3K/AKT/mTOR Pathway
by: Xiaoyang Wu, et al.
Published: (2022-04-01)

Bovine collagen oligopeptides accelerate wound healing by promoting fibroblast migration via PI3K/Akt/mTOR signaling pathway
by: Lei Bao, et al.
Published: (2022-03-01)

Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway.
by: Hideki Tomioka, et al.
Published: (2014-01-01)

mTOR inhibitors in a patient with lupus nephritis; why not?
by: Raquel Berzal, et al.
Published: (2023-12-01)

mTOR inhibitors in a patient with lupus nephritis; why not?
by: Raquel Berzal, et al.
Published: (2023-12-01)

Recent advances and limitations of mTOR inhibitors in the treatment of cancer
by: Eunus S. Ali, et al.
Published: (2022-09-01)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
by: Lampidis Theodore, et al.
Published: (2005-07-01)

Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake.
by: PLOS ONE Staff
Published: (2014-01-01)

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
by: Keiko Shoji, et al.
Published: (2012-01-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
by: Victor H. Villar, et al.
Published: (2017-05-01)

INK128 exhibits synergy with azoles against Exophiala spp. and Fusarium spp.
by: Lujuan Gao, et al.
Published: (2016-10-01)

Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia
by: Hadley, G, et al.
Published: (2019)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
by: Alexandre el Hage, et al.
Published: (2021-03-01)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
by: Mathis Wehming, et al.
Published: (2023-02-01)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
by: Wei Zhao, et al.
Published: (2023-06-01)

Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway
by: Julian A. Martinez-Agosto, et al.
Published: (2012-10-01)

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
by: Kay Andrea, et al.
Published: (2009-10-01)

mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients
by: Reece Jefferies, et al.
Published: (2022-02-01)

Management of mTOR inhibitors oral mucositis: current state of knowledge
by: Calvo Anne Sophie, et al.
Published: (2019-01-01)

Perivascular Epithelioid Cell Tumors (PEComas) Refractory to mTOR Inhibitors
by: San-Chi Chen, et al.
Published: (2014-09-01)

The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
by: Yimei Feng, et al.
Published: (2021-01-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Experimental Approaches in Delineating mTOR Signaling
by: Jiayi Qian, et al.
Published: (2020-07-01)

mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01)

mTOR signaling cascade in psoriatic disease: Double kinase mtor inhibitor a novel therapeutic target
by: Smriti K Raychaudhuri, et al.
Published: (2014-01-01)